Does LAZERTINIB Cause Deep vein thrombosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Deep vein thrombosis have been filed in association with LAZERTINIB (LAZCLUZE). This represents 1.4% of all adverse event reports for LAZERTINIB.
5
Reports of Deep vein thrombosis with LAZERTINIB
1.4%
of all LAZERTINIB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Deep vein thrombosis From LAZERTINIB?
Of the 5 reports, 1 (20.0%) resulted in death, 3 (60.0%) required hospitalization.
Is Deep vein thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAZERTINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LAZERTINIB Cause?
Rash (77)
Neuropathy peripheral (32)
Infusion related reaction (30)
Fatigue (26)
Diarrhoea (20)
Off label use (19)
Paronychia (16)
Pruritus (13)
Nausea (12)
Dyspnoea (11)
What Other Drugs Cause Deep vein thrombosis?
LENALIDOMIDE (3,286)
RIVAROXABAN (3,180)
TESTOSTERONE (2,213)
APIXABAN (1,944)
ETHINYL ESTRADIOL\ETONOGESTREL (1,577)
RITUXIMAB (1,287)
METHOTREXATE (1,146)
DROSPIRENONE\ETHINYL ESTRADIOL (1,139)
DEXAMETHASONE (1,067)
ADALIMUMAB (1,056)
Which LAZERTINIB Alternatives Have Lower Deep vein thrombosis Risk?
LAZERTINIB vs LEBRIKIZUMAB-LBKZ
LAZERTINIB vs LECANEMAB
LAZERTINIB vs LECANEMAB-IRMB
LAZERTINIB vs LECITHIN\POLOXAMER 407
LAZERTINIB vs LEDIPASVIR